GSK PLC's ticker is and the CUSIP is 37733W204. A total of 63 filers reported holding GSK PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $118,139 | -23.4% | 3,259 | -24.6% | 0.03% | -16.7% |
| Q2 2023 | $154,143 | +0.2% | 4,325 | 0.0% | 0.04% | +5.9% |
| Q1 2023 | $153,884 | +2.7% | 4,325 | +1.4% | 0.03% | 0.0% |
| Q4 2022 | $149,907 | +19.0% | 4,266 | 0.0% | 0.03% | -38.2% |
| Q3 2022 | $126,000 | -45.7% | 4,266 | -20.0% | 0.06% | -1.8% |
| Q2 2022 | $232,000 | – | 5,333 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 13,993,208 | $497,808 | 52.84% |
| Eversept Partners, LP | 3,731,499 | $133,929,238 | 9.34% |
| Camber Capital Management LP | 4,600,000 | $163,668 | 5.03% |
| Callodine Capital Management, LP | 450,000 | $16,011,000 | 4.72% |
| EQUITY INVESTMENT CORP | 3,300,231 | $117,422,219 | 3.85% |
| Robinson Value Management, Ltd. | 128,939 | $4,587,650 | 3.52% |
| Hillman Capital Management, Inc. | 237,416 | $8,447,261 | 3.20% |
| Keystone Financial Planning, Inc. | 262,982 | $9,356,885 | 3.18% |
| Clean Yield Group | 198,160 | $7,050,533 | 3.00% |
| CLIFFORD CAPITAL PARTNERS LLC | 266,755 | $9,491,143 | 2.92% |